Document is current
Any future updates will be listed below
-
Authors
Drobni, Zsofia Dora https://orcid.org/0000-0002-1355-5318
Gongora, Carlos
Taron, Jana
Suero-Abreu, Giselle A
Karady, Julia
Gilman, Hannah K
Supraja, Sama
Nikolaidou, Sofia
Leeper, Nicolas
Merkely, Béla
Maurovich-Horvat, Pal
Foldyna, Borek
Neilan, Tomas G
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04430712 at ClinicalTrials.govnct04430712 at ClinicalTrials.govDocuments that mention this clinical trial
Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
https://doi.org/10.1136/jitc-2023-007307
Documents that mention this clinical trial
Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
https://doi.org/10.1136/jitc-2023-007307
-
Funding
Funding for this research was provided by:
Hassenfeld Scholar Award
Innovációs és Technológiai Minisztérium (2020-4.1.1.-TKP2020)
Innovációs és Technológiai Minisztérium (NVKP_16-1–2016-0017)
Innovációs és Technológiai Minisztérium (ÚNKP-22-4-II-SE)
Deutsche Forschungsgemeinschaft (TA 1438/1-2. T)
A. Curt Greer and Pamela Kohlberg, the Michael and Kathryn Park Endowed Chair in Cardiology
AstraZeneca (NCT04430712)
National Heart, Lung, and Blood Institute (R01HL130539, R01HL137562, R01HL159187, K24HL150238)
- License Information
